Literature DB >> 17522300

A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.

Lynsey Meikle1, Delia M Talos, Hiroaki Onda, Kristen Pollizzi, Alexander Rotenberg, Mustafa Sahin, Frances E Jensen, David J Kwiatkowski.   

Abstract

Tuberous sclerosis (TSC) is a hamartoma syndrome caused by mutations in TSC1 or TSC2 in which cerebral cortical tubers and seizures are major clinical issues. We have engineered mice in which most cortical neurons lose Tsc1 expression during embryonic development. These Tsc1 mutant mice display several neurological abnormalities beginning at postnatal day 5 with subsequent failure to thrive and median survival of 35 d. The mice also display clinical and electrographic seizures both spontaneously and with physical stimulation, and some seizures end in a fatal tonic phase. Many cortical and hippocampal neurons are enlarged and/or dysplastic in the Tsc1 mutant mice, strongly express phospho-S6, and are ectopic in multiple sites in the cortex and hippocampus. There is a striking delay in myelination in the mutant mice, which appears to be caused by an inductive neuronal defect. This new TSC brain model replicates several features of human TSC brain lesions and implicates an important function of Tsc1/Tsc2 in neuronal development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522300      PMCID: PMC6672762          DOI: 10.1523/JNEUROSCI.5540-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

1.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice.

Authors:  X Mao; Y Fujiwara; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.

Authors:  R F Lamb; C Roy; T J Diefenbach; H V Vinters; M W Johnson; D G Jay; A Hall
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

3.  Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.

Authors:  Y Niida; A O Stemmer-Rachamimov; M Logrip; D Tapon; R Perez; D J Kwiatkowski; K Sims; M MacCollin; D N Louis; V Ramesh
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

4.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

5.  Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).

Authors:  Elena A Goncharova; Dmitry A Goncharov; Andrew Eszterhas; Deborah S Hunter; Marilyn K Glassberg; Raymond S Yeung; Cheryl L Walker; Daniel Noonan; David J Kwiatkowski; Margaret M Chou; Reynold A Panettieri; Vera P Krymskaya
Journal:  J Biol Chem       Date:  2002-06-03       Impact factor: 5.157

6.  The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.

Authors:  G Benvenuto; S Li; S J Brown; R Braverman; W C Vass; J P Cheadle; D J Halley; J R Sampson; R Wienecke; J E DeClue
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

Review 7.  Molecular genetic advances in tuberous sclerosis.

Authors:  J P Cheadle; M P Reeve; J R Sampson; D J Kwiatkowski
Journal:  Hum Genet       Date:  2000-08       Impact factor: 4.132

8.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.

Authors:  David J Kwiatkowski; Hongbing Zhang; Jennifer L Bandura; Kristina M Heiberger; Michael Glogauer; Nisreen el-Hashemite; Hiroaki Onda
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

Review 9.  Axonal control of oligodendrocyte development.

Authors:  B A Barres; M C Raff
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis.

Authors:  K Ridler; E T Bullmore; P J De Vries; J Suckling; G J Barker; S J Meara; S C Williams; P F Bolton
Journal:  Psychol Med       Date:  2001-11       Impact factor: 7.723

View more
  238 in total

1.  Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.

Authors:  Jurriaan M Peters; Mustafa Sahin; Vanessa K Vogel-Farley; Shafali S Jeste; Charles A Nelson; Matthew C Gregas; Sanjay P Prabhu; Benoit Scherrer; Simon K Warfield
Journal:  Acad Radiol       Date:  2012-01       Impact factor: 3.173

2.  Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders.

Authors:  William W Lewis; Mustafa Sahin; Benoit Scherrer; Jurriaan M Peters; Ralph O Suarez; Vanessa K Vogel-Farley; Shafali S Jeste; Matthew C Gregas; Sanjay P Prabhu; Charles A Nelson; Simon K Warfield
Journal:  Cereb Cortex       Date:  2012-06-01       Impact factor: 5.357

3.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

4.  Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy.

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

5.  Vigabatrin can enhance electroretinographic responses in pigmented and albino rats.

Authors:  James D Akula; Emily R Noonan; Alessia Di Nardo; Tara L Favazza; Nan Zhang; Mustafa Sahin; Ronald M Hansen; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2015-03-12       Impact factor: 2.379

6.  The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Lirong Han; Brennan Beeler; Joseph L Friedman; Elizabeth Griffin; Yue-Shan Piao; Nicholas R Rensing; Michael Wong
Journal:  Epilepsia       Date:  2018-08-05       Impact factor: 5.864

Review 7.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

8.  Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex.

Authors:  Leonardo Emberti Gialloreti; Romina Moavero; Sara Marciano; Matteo Pardini; Francesca Benassi; Maria Giulia Mutolo; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2015-04-25       Impact factor: 1.475

Review 9.  Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.

Authors:  Ken Inoki; Kun-Liang Guan
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

10.  Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.

Authors:  Peter T Tsai; Emily Greene-Colozzi; June Goto; Stefanie Anderl; David J Kwiatkowski; Mustafa Sahin
Journal:  Behav Genet       Date:  2012-12-12       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.